Hardean E. Achneck's most recent trade in Aligos Therapeutics Inc was a trade of 75,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Oct. 8, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aligos Therapeutics Inc | Hardean E. Achneck | Chief Medical Officer | 08 Oct 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) |